Paul.jnxy
I cruise on your blast - buccal
- Joined
- Jan 10, 2026
- Posts
- 1,838
- Reputation
- 2,260
The term Aromasin only supresses 36% of serum e2 in healthy male homosapiens is heavily misused or not understood in the community by the likes of, well, me.
"Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males."
Link
Its a short fucking read so if you can't read through it you are a fucking Attentionspancel.
"Exemestane suppressed plasma estradiol comparably with either dose [25 mg, 38% (P ≤ 0.002); 50 mg, 32% (P ≤ 0.008)], with a reciprocal increase in testosterone concentrations (60% and 56%; P ≤ 0.003 for both)."
This is the exact quote straight from the paper.
Here is the FUCKING FLAW: They only ran 25 mg in healthy men FOR 10 FUCKING DAYS. That's it.
50 mg only suppressed 32% while 25 mg suppressed 38%. This shows the study was too fucking short to reach a steady effect.
Now you may ask if we actually know aromasins suppression.
The Answer is actually YES we might from a couple sources even.
Official Prescribing Information (FDA / Pfizer Label)
Exact quote:
"Plasma estrogen (estradiol, estrone, and estrone sulfate) suppression was seen starting at a 5 mg daily dose of exemestane, with a maximum suppression of at least 85% to 95% achieved at a 25-mg dose. Exemestane 25 mg daily reduced whole body aromatization (as measured by injecting radiolabeled androstenedione) by 98% in postmenopausal women with breast cancer."
Does this apply to you? Not really. Yet men and women aromatese the same fucking way so the dif is unprobable to be huge.
Couple more studies showing exemestane might be decent:
-https://jamanetwork.com/journals/jamaoncology/fullarticle/2802824#:~:text=Serrano%20D%2C%20Gandini%20S%2C%20Thomas%20P%2C%20et%20al.,Oncol.%202023%3B9%20%285%29%3A664%E2%80%93672.%20doi%3A10.1001%2Fjamaoncol.2023.0089%20Supplement%201.%20eTable%201.
-
pubmed.ncbi.nlm.nih.gov
No spellcheck or anything as I am on my bike cycling back home from the gym.
Tagging random nighas: @Niebvll @zennn @anondude @alexbrown8384 @strongmtn @ICL @stacyslayer.12569 idk forgot some ppl probably.
Wish me luck on my math finals tmrw morning
"Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males."
Link
Its a short fucking read so if you can't read through it you are a fucking Attentionspancel.
"Exemestane suppressed plasma estradiol comparably with either dose [25 mg, 38% (P ≤ 0.002); 50 mg, 32% (P ≤ 0.008)], with a reciprocal increase in testosterone concentrations (60% and 56%; P ≤ 0.003 for both)."
This is the exact quote straight from the paper.
Here is the FUCKING FLAW: They only ran 25 mg in healthy men FOR 10 FUCKING DAYS. That's it.
50 mg only suppressed 32% while 25 mg suppressed 38%. This shows the study was too fucking short to reach a steady effect.
Now you may ask if we actually know aromasins suppression.
The Answer is actually YES we might from a couple sources even.
Official Prescribing Information (FDA / Pfizer Label)
Exact quote:
"Plasma estrogen (estradiol, estrone, and estrone sulfate) suppression was seen starting at a 5 mg daily dose of exemestane, with a maximum suppression of at least 85% to 95% achieved at a 25-mg dose. Exemestane 25 mg daily reduced whole body aromatization (as measured by injecting radiolabeled androstenedione) by 98% in postmenopausal women with breast cancer."
Does this apply to you? Not really. Yet men and women aromatese the same fucking way so the dif is unprobable to be huge.
Couple more studies showing exemestane might be decent:
-https://jamanetwork.com/journals/jamaoncology/fullarticle/2802824#:~:text=Serrano%20D%2C%20Gandini%20S%2C%20Thomas%20P%2C%20et%20al.,Oncol.%202023%3B9%20%285%29%3A664%E2%80%93672.%20doi%3A10.1001%2Fjamaoncol.2023.0089%20Supplement%201.%20eTable%201.
-
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients - PubMed
The effect of exemestane (6-methylenandrosta-1,4-diene-3,17-dione) 25 mg p.o. once daily on in vivo aromatization was studied in 10 postmenopausal women with advanced breast cancer. Aromatization was determined before treatment and after 6-8 weeks on therapy by administering a bolus injection of...
No spellcheck or anything as I am on my bike cycling back home from the gym.
Tagging random nighas: @Niebvll @zennn @anondude @alexbrown8384 @strongmtn @ICL @stacyslayer.12569 idk forgot some ppl probably.
Wish me luck on my math finals tmrw morning


